Cloning and characterization of a novel feline IFN-omega

J Interferon Cytokine Res. 2007 Feb;27(2):119-27. doi: 10.1089/jir.2006.0094.

Abstract

The interferons (IFNs) are a large family of multifunctional secreted protein involved in antiviral defense, cell growth regulation, and immune activation. The human IFNs are used worldwide as antiviral drugs. Here, we present cDNAs encoding 13 novel feline IFN-omega (FeIFN-omega) subtypes that share 95%-99% amino acid sequence identity. FeIFN-omega2 and FeIFN-omega4 have seven additional amino acids at position 109 that are not present in other subtypes. Sequence identity of the present FeIFN proteins encoded by the 13 subtypes is approximately 57% compared with human IFN-omega (HuIFN-omega). All 13 FeIFN-omega subtypes were expressed in Escherichia coli using a periplasmic expression system. The antiviral activity of each product was evaluated in vitro. In addition, subtype FeIFN-omega2 was cytoplasm expressed in E. coli and secretion expressed in Pichia pastoris. The purified mature recombinant protein demonstrated significant antiviral activity on both homologous and heterologous animal cells in vitro.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antiviral Agents* / metabolism
  • Antiviral Agents* / pharmacology
  • Cats
  • Cattle
  • Cloning, Molecular
  • Cytopathogenic Effect, Viral / drug effects
  • Dogs
  • Interferon Type I* / biosynthesis
  • Interferon Type I* / genetics
  • Interferon Type I* / pharmacology
  • Molecular Sequence Data
  • Recombinant Proteins / biosynthesis
  • Recombinant Proteins / genetics
  • Recombinant Proteins / pharmacology
  • Rhabdoviridae Infections / drug therapy
  • Rhabdoviridae Infections / veterinary
  • Vesicular stomatitis Indiana virus

Substances

  • Antiviral Agents
  • Interferon Type I
  • Recombinant Proteins
  • interferon omega 1